Is Herbalife Ltd. overvalued or undervalued?

As of 22 February 2018, the valuation grade for Herbalife Ltd. has moved from very expensive to risky. Based on the current analysis, the company appears to be undervalued. The P/E ratio stands at 3, significantly lower than the industry average, while the EV to EBITDA ratio is 4.95 and the PEG ratio is an exceptionally low 0.06, indicating potential for growth relative to its price.
In comparison to peers, Sally Beauty Holdings, Inc. is rated as very attractive with a P/E of 4.62, while Myomo, Inc. is also considered risky with a negative P/E of -17.02. Herbalife's return over the past year is notably poor at -26.92%, contrasting sharply with the S&P 500's return of 10.26%, which further emphasizes the potential mispricing in the stock. Overall, the combination of low valuation ratios and peer comparisons suggests that Herbalife Ltd. is currently undervalued in the market.